FinancialPress releases

Q1 Interim report July – September 2023

By November 17, 2023 January 2nd, 2024 No Comments

English

 

Swedish

Related Posts

Press releases

Clinical data from patients with bladder pain syndrome support anakinra (IL1-RA) as a new, successful treatment option

Hamlet Biopharma
Hamlet BiopharmaMay 6, 2024
Press releases

Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group

Hamlet Biopharma
Hamlet BiopharmaApril 18, 2024
Press releases

Alpha1H to be the first asset for the commercial collaboration

Hamlet Biopharma
Hamlet BiopharmaApril 11, 2024
Hamlet Biopharma

Author Hamlet Biopharma

More posts by Hamlet Biopharma

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish